$GRML Cashflow Statement | Understand Stock

$GRML

$5.79 +$0.01 (0.17%) Close

$GRML Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Change in fair value of warrant liabilities
Interest earned on investment held in Trust Account
Changes in fair value of warrant liability
Commitment fee
Impairment on intangible assets
Interest expense
Settlement on note payable
Conversion of debt to equity
Consulting fees
Stock-based compensation

Changes in operating assets and liabilities:
Prepaid expenses
Accounts payable
Accrued expenses
Deferred income tax liability
Franchise tax payable
Income tax payable
Deferred income tax payable
Tax payable
Related party payable
Other Liabilities
Net cash used in operating activities

CASH FLOWS FROM INVESTING ACTIVITIES:
Acquisition of patents
Acquisition of drug license
Cash withdrawn from Trust Account to pay taxes
Cash withdrawn from Trust Account to pay redeemed public stockholders
Cash deposited into Trust Account for term extension
Net cash used in investing activities
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from convertible promissory note, net of issuance cost
Proceeds from sales of stocks and warrants, net
Proceeds from stock subscriptions
Proceeds from sale of preferred B shares
Payments on notes payable
Payments for deferred financing costs
Proceeds from FPA settlement
Payments on financed director and officer insurance
Proceeds from At-the-Market sales of common shares
Proceeds from sale of public units through public offering
Proceeds from sale of private placement units
Proceeds from sale of unit purchase option
Proceeds from related party loans
Advance from related party
Payment to redeemed public stockholders
Repayment of promissory note to related party
Repayment of advance from related party
Payment of underwriters’ commissions
Payment of deferred offering costs
Proceeds from shareholders
Payments to shareholders
Merger proceeds net of transaction cost
Repayment of advance to shareholder
Net cash provided by financing activities
Net change in cash

NET CHANGE IN CASH
Cash - Beginning of period
Cash - End of period
SUPPLEMENTAL NON-CASH FINANCING AND INVESTING ACTIVITIES:
Note payable settled with issuance of common stock
Interest payable settled with issuance of common stock
Reversal of OID
Repurchase of warrants
Issuance of warrants
Discretionary non-cash payment to creditor with issuance of common stock
Conversion of Preferred B Shares to common stock
Deemed dividend - warrant modification
Non-cash equity payment for inducement fee on note payable
Non-cash directors’ and officers’ insurance
Non-cash PIPE Funds used for merger transaction close
Assumed income tax payable
Conversion of warrants to common shares
Commitment fee paid in stock
Assumed income tax payable from merger
Assumed warrant liability from merger
Warrant conversion
SUPPLEMENTAL CASH FLOW INFORMATION:
Initial classification of common stock subject to redemption
Initial recognition of warrant liabilities
Deferred underwriting fee payable
Allocation of offering costs to common stock subject to redemption
Accretion of Common stock to redemption value
Excise tax liability
Interest Paid
Taxes Paid

Comments